LIFR and neoplasm: LIFR showed the highest expression in midbrain, followed by basal ganglia and thalamus, with low tissue specificity (Figure S1A), while low expression of LIFR was detected in most tumor cell lines, with higher expression in AF22 (brain), SCLC-21H (lung) and HHSteC lines (mesenchymal) (Figure S1B).